Wolverine Asset Management’s Cidara Therapeutics CDTX Stock Holding History

Wolverine Asset Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,050	Closed	-$453K	–	1726
2025 Q4	$453K	Buy	+2,050	New	+$331K	﹤0.01%	950

Wolverine Asset Management's CDTX Position: Q1 2026 in Review

Wolverine Asset Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 2,050 shares — an estimated $453K sold.

Wolverine Asset Management first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $453K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Wolverine Asset Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Wolverine Asset Management sold 2,050 Cidara Therapeutics shares in Q1 2026, an estimated $453K.
Wolverine Asset Management first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Wolverine Asset Management's Cidara Therapeutics position peaked at $453K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.